Cargando…
The value of magnetic resonance imaging as a biomarker for amyotrophic lateral sclerosis: a systematic review
BACKGROUND: Amyotrophic lateral sclerosis (ALS) is a fatal, rapidly progressive neurodegenerative disease that mainly affects the motor system. A number of potentially neuroprotective and neurorestorative disease-modifying drugs are currently in clinical development. At present, the evaluation of a...
Autores principales: | Grolez, G., Moreau, C., Danel-Brunaud, V., Delmaire, C., Lopes, R., Pradat, P. F., El Mendili, M. M., Defebvre, L., Devos, D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5002331/ https://www.ncbi.nlm.nih.gov/pubmed/27567641 http://dx.doi.org/10.1186/s12883-016-0672-6 |
Ejemplares similares
-
Neuroimaging to Investigate Multisystem Involvement and Provide Biomarkers in Amyotrophic Lateral Sclerosis
por: Pradat, Pierre-François, et al.
Publicado: (2014) -
Could Conservative Iron Chelation Lead to Neuroprotection in Amyotrophic Lateral Sclerosis?
por: Moreau, Caroline, et al.
Publicado: (2018) -
A ferroptosis–based panel of prognostic biomarkers for Amyotrophic Lateral Sclerosis
por: Devos, David, et al.
Publicado: (2019) -
Magnetic Resonance Imaging Features of the Nigrostriatal System: Biomarkers of Parkinson’s Disease Stages?
por: Hopes, Lucie, et al.
Publicado: (2016) -
Author Correction: A ferroptosis–based panel of prognostic biomarkers for Amyotrophic Lateral Sclerosis
por: Devos, David, et al.
Publicado: (2020)